Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial-Reference-Cited by-同舟云学术

Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial

Published:2021-07-18 Issue:9 Volume:19 Page:2225-2234
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Perepu Usha S.¹,Chambers Isaac¹,Wahab Abdul¹,Ten Eyck Patrick²,Wu Chaorong²,Dayal Sanjana¹^ORCID,Sutamtewagul Grerk¹,Bailey Steven R.³,Rosenstein Lori J.⁴,Lentz Steven R.¹^ORCID

Affiliation:

1. Department of Internal Medicine University of Iowa Iowa City Iowa USA

2. Institute for Clinical and Translational Science University of Iowa Iowa City Iowa USA

3. Department of Internal Medicine LSU Health Shreveport Shreveport Louisiana USA

4. Gunderson Health System La Crosse Wisconsin USA

Funder

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15450

Reference35 articles.

1. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

2. COVID-19 and its implications for thrombosis and anticoagulation

3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

4. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

5. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular histones: a unifying mechanism driving platelet-dependent extracellular vesicle release and thrombus formation in COVID-19;Journal of Thrombosis and Haemostasis;2024-09

2. Challenges of consolidating evidence collected during a pandemic and lessons for the future;Current Medical Research and Opinion;2024-07-23

3. Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis;Thrombosis Research;2024-06

4. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19;Journal of Thrombosis and Haemostasis;2024-06

5. The effect of current antithrombotic therapy on mortality in nursing home residents with COVID-19: a multicentre retrospective cohort study;Age and Ageing;2024-05-01